Align your market access strategy with the latest developments shaping the pharmaceutical industry.

CONFERENCE CO-CHAIRS
Speaker Name

Andrea Masters

Strategic Access & Pricing Director
Hoffmann-La Roche Limited

Speaker Name

Rebecca Vieira

Head of Access and Pricing
Vertex Pharmaceuticals

Distinguished Faculty
Speaker Name

Gail Attara

President
Gastrointestinal Society

Speaker Name

Tara Cowling

President
Medlior

Speaker Name

Julie Frappier

President & Founder, TOWWERS Program
Data4Actions

Speaker Name

Guillaume Couillard

Executive Director
PMPRB

Speaker Name

Alex Chambers

Senior Market Access Manager
Bayer Inc.

Speaker Name

Mina Tadrous

Assistant Professor, Leslie Dan Faculty of Pharmacy
University of Toronto

Why Attend

Join our 10th Anniversary Forum and start the year off with a full view of all the moving pieces impacting drug access decisions.

This is your chance to benchmark with the leading manufacturers, payors, and regulators, as they examine the evolving role of RWE and innovative market access mechanisms, including CADTH’s time limited recommendation and the pCPA’s temporary access process. Learn how to identify opportunities to improve your submissions and work with key stakeholders to expedite drug to market timelines.

iconANTICIPATE the impact of the national pharmacare on patients and payers

iconCONNECT with decision-makers, incl. CADTH, pCPA, and INESSS

iconIDENTIFY and address potential regulatory hurdles early in your access strategy

iconGAIN insights on packaging RWE to support the value proposition of your product

iconASSESS emerging tools, and technology that can support market access functions

WHO YOU WILL MEET

Practitioners at every level with experience in:

  • Pricing
  • Reimbursement
  • Market access
  • Patient access
  • Government and regulatory affairs
  • Health economics
  • Research and development
  • Policy and compliance
  • Pharmacy services
  • Marketing
  • National trade
  • Formularies
  • Business development
  • Sales

From brand generic and manufacturing companies involved in:

  • Product development
  • Public drug programs
  • Pharmaceutical benefits
  • Pharmaceutical strategy
  • Drug submissions
  • Formulary management
  • Policy and economic analysis
  • Provider services and
  • relations
  • Pharmacy

And representatives from:

  • Associations
  • Patient Advocacy Groups
Testimonials
Quote Icon

Great overview, gave me a different perspective. Got me thinking differently.

Team Lead, Pricing and Contracts, GSK
Quote Icon

I liked the quality of the speakers.

Manager, Market Access and HTA, BMS
Quote Icon

Overall excellent topics and speakers. Truly enjoyed the selection of speakers and the panels.

Manager, Pricing and Contracts, Astellas:
Related Conferences
Event Thumbnail Image
Event Thumbnail Image
Event Thumbnail Image